CONCLUSIONS
Although
individual studies have not yet convincingly shown a survival advantage
with maintenance chemotherapy in OC, this meta-analysis demonstrates
that continued chemotherapy after completion of primary therapy for OC
improves PFS and OS. Benefits are greatest in patients with advanced
stage OC who reach complete clinical or pathologic response after
primary therapy.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.